APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 30, 2019 for PCR Investments Ltd 2020: Prognosis positive for healthcare sector
Apollo Hospitals Group MD Suneeta Reddy said, "The prognosis is positive." Apollo Hospitals Enterprise Ltd - 508869 - Closure of Trading Window
Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company will, inter alia, consider the approval of the unaudited financial results for the quarter and nine months ending December 31, 2019 at its Meeting to be held on Thursday, February 13, 2020. Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window will remain closed from January 1, 2020 to February 15, 2020 (both days inclusive) for Directors and Designated Persons. Please take note of the above in your records. Apollo Hospitals Enterprise Ltd - 508869 - Board Meeting Intimation for Board Meeting For Approval Of Unaudited Financial Results
APOLLO HOSPITALS ENTERPRISE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company will, inter alia, consider the approval of the unaudited financial results for the quarter and nine months ending December 31, 2019 at its Meeting to be held on Thursday, February 13, 2020. Pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended, the Trading Window will remain closed from January 1, 2020 to February 15, 2020 (both days inclusive) for Directors and Designated Persons. Please take note of the above in your records. Sangita Reddy is FICCI President
Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, has taken over as the President of industry chamber FICCI for 2019-20. She succeeds S Apollo Hospitals Enterprise Ltd - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Sub: Intimation in terms of Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Regulations) regarding loss of share certificate. This is to inform you that the Company has received intimation from shareholder on December 21, 2019 regarding loss of share certificate. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificate are as given below: Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos. 4203 T. R. Leelamani 200 354204 5596297 to 5596496 This is for your information. APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on December 13, 2019 for Preetha Reddy APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 13, 2019 for Preetha Reddy Apollo Hospitals Enterprise Ltd - 508869 - Disclosure Of Related Party Transactions Pursuant Under Reg.23(9) Of The SEBI (Listing Obligations And Disclosure Requirements} Regulations, 2015 {"SEBI (LODR}")
This is further to our letter dated 14th November 2019 and pursuant to Regulation 23(9) of the SEBI (LODR), please find enclosed herewith the disclosure of related party transactions on a consolidated basis and balances for the half year ended 30th September 2019. The said disclosure is being made available in the company''s website www.apollohospitals.com Kindly take the above information on records.